Literature DB >> 28800794

Long Intergenic Noncoding RNA 319 (linc00319) Promotes Cell Proliferation and Invasion in Lung Cancer Cells by Directly Downregulating the Tumor Suppressor MiR-32.

Bo Zhou1, Wenwen Yuan1, Xinping Li1.   

Abstract

Long non-coding RNAs (lncRNAs) have been shown to play important regulatory roles in the pathogenesis and progression of multiple cancers. Here, we investigated the role of long intergenic non coding RNA 319 (linc00319) in the proliferation and invasion of lung cancer cells. We found that, compared with normal lung cell line HBE, linc00319 was increased in low metastatic lung cancer cell lines PAa and AgiY-83a, and further increased in high metastatic lung cancer cell lines A549 and Anip-973. Then, different concentrations of pcDNA-linc00319 expression vector and different concentrations of linc00319 siRNA were respectively transfected into A549 lung cancer cells. The results showed that linc00319 increased the proliferation and invasion of A549 cells, and suppressed cell apoptosis, in a dose-dependent manner. In contrast, linc00319 siRNA suppressed A549 cell proliferation and invasion, and promoted cell apoptosis, in a dose-dependent manner. The online bioinformatic tool RNAhybrid revealed that linc00319 potentially bound with the miR-32, which functioned as a tumor suppressor in lung cancer. Luciferase acitivity and RNA pull-down assays comfirmed that linc00319 directly bound with miR-32. Linc00319 could negatively regulate the expression of miR-32 and positively regulate the protein levels of miR-32 target genes, including AURKA, SOX9 and TWIST1. In conclusion, linc00319 promotes cell proliferation and invasion in lung cancer cells by directly binding with and downregulating the tumor suppressor miR-32.

Entities:  

Year:  2017        PMID: 28800794     DOI: 10.3727/096504017X15016337254650

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  8 in total

1.  Identification of prognostic candidate signatures by systematically revealing transcriptome characteristics in lung adenocarcinoma with differing tumor microenvironment immune phenotypes.

Authors:  Qiang Chen; Jiakang Ma; Xiaoyi Wang; Xiangqing Zhu
Journal:  Aging (Albany NY)       Date:  2022-06-07       Impact factor: 5.955

2.  Effects and mechanism of microRNA‑218 against lung cancer.

Authors:  Yan Chen; Ji-Lin Yang; Zhen-Zhen Xue; Qiu-Chen Cai; Chun Hou; Hong-Juan Li; Liu-Xin Zhao; Yin Zhang; Cheng-Wei Gao; Li Cong; Tian-Zuo Wang; Dong-Mei Chen; Guo-Sheng Li; Shi-Qing Luo; Qian Yao; Chan-Juan Yang; Qi-Shun Zhu; Chuan-Hai Cao
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

3.  CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis.

Authors:  Xiao Jiang; Jingpeng Liu; Simin Li; Bo Jia; Zhijie Huang; Jun Shen; Haiyun Luo; Jianjiang Zhao
Journal:  Cell Death Dis       Date:  2020-09-18       Impact factor: 8.469

4.  A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.

Authors:  Rang Li; Kedong Han; Dehua Xu; Xiaolin Chen; Shujin Lan; Yuanjun Liao; Shengnan Sun; Shaoqi Rao
Journal:  Front Genet       Date:  2021-01-28       Impact factor: 4.599

5.  LINC00319 promotes cancer stem cell-like properties in laryngeal squamous cell carcinoma via E2F1-mediated upregulation of HMGB3.

Authors:  Linlin Yuan; Xiufen Tian; Yanfei Zhang; Xinhui Huang; Qing Li; Wencai Li; Shenglei Li
Journal:  Exp Mol Med       Date:  2021-08-18       Impact factor: 8.718

6.  Upregulated LINC00319 aggravates neuronal injury induced by oxygen-glucose deprivation via modulating miR-200a-3p.

Authors:  Hui Yang; He Wang; Xiaodan Zhang; Yuehan Yang; Hongbin Li
Journal:  Exp Ther Med       Date:  2021-06-07       Impact factor: 2.447

7.  LINC00319-Mediated miR-3127 Repression Enhances Bladder Cancer Progression Through Upregulation of RAP2A.

Authors:  Xiaoqing Wang; Ran Meng; Qing-Mei Hu
Journal:  Front Genet       Date:  2020-03-03       Impact factor: 4.599

8.  A fourteen-lncRNA risk score system for prognostic prediction of patients with non-small cell lung cancer.

Authors:  Jia-Yi Song; Xiao-Ping Li; Xiu-Jiao Qin; Jing-Dong Zhang; Jian-Yu Zhao; Rui Wang
Journal:  Cancer Biomark       Date:  2020       Impact factor: 4.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.